Selectis Health (GBCS) Short term Debt (2011 - 2025)

Selectis Health has disclosed Short term Debt across 14 years of filings, most recently posting $17.5 million for Q4 2025.

• Short term Debt for Q4 2025 came in at $17.5 million, up 52.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $17.5 million (up 52.83% YoY), and the FY2025 annual result was $17.5 million, up 52.83% from the prior year.
• Short term Debt came in at $17.5 million for Q4 2025 at Selectis Health, up from $11.8 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $17.5 million in Q4 2025 to a low of $150000.0 in Q2 2022.
• The 5-year median for Short term Debt is $10.7 million (2023), against an average of $8.6 million.
• Across the five-year window, Short term Debt plunged 97.92% in 2022 and jumped 7089.05% in 2023, its largest moves.
• Selectis Health's Short term Debt stood at $6.3 million in 2021, then sank by 63.61% to $2.3 million in 2022, then jumped by 386.33% to $11.2 million in 2023, then grew by 2.51% to $11.5 million in 2024, then surged by 52.83% to $17.5 million in 2025.
• The last three Short term Debt figures came in at $17.5 million (Q4 2025), $11.8 million (Q3 2025), and $11.3 million (Q2 2025), per Business Quant data.